Ocular Hypertension Global Clinical Trials Review, H1, 2015

Date: June 11, 2015
Pages: 102
Price:
US$ 2,500.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: O1C8FDF9795EN
Leaflet:

Download PDF Leaflet

Ocular Hypertension Global Clinical Trials Review, H1, 2015
Ocular Hypertension Global Clinical Trials Review, H1, 2015

SUMMARY

GlobalData's clinical trial report, 'Ocular Hypertension Global Clinical Trials Review, H1, 2015' provides an overview of Ocular Hypertension clinical trials scenario. This report provides top line data relating to the clinical trials on Ocular Hypertension. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

SCOPE
  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

REASONS TO BUY
  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Introduction
Ocular Hypertension
Report Guidance
Clinical Trials by Region
Clinical Trials and Average Enrollment by Country
Top Five Countries Contributing to Clinical Trials in Asia-Pacific
Top Five Countries Contributing to Clinical Trials in Europe
Top Countries Contributing to Clinical Trials in North America
Top Five Countries Contributing to Clinical Trials in Middle East and Africa
Top Five Countries Contributing to Clinical Trials in Central and South America
Clinical Trials by G7 Countries: Proportion of Ocular Hypertension to Ophthalmology Clinical Trials
Clinical Trials by Phase in G7 Countries
Clinical Trials in G7 Countries by Trial Status
Clinical Trials by E7 Countries: Proportion of Ocular Hypertension to Ophthalmology Clinical Trials
Clinical Trials by Phase in E7 Countries
Clinical Trials in E7 Countries by Trial Status
Clinical Trials by Phase
In Progress Trials by Phase
Clinical Trials by Trial Status
Clinical Trials by End Point Status
Unaccomplished Trials of Ocular Hypertension
Subjects Recruited Over a Period of Time
Clinical Trials by Sponsor Type
Prominent Sponsors
Top Companies Participating in Ocular Hypertension Therapeutics Clinical Trials
Prominent Drugs
Latest Clinical Trials News on Ocular Hypertension
May 11, 2015: Promising preclinical data on NCX 667 for glaucoma presented at ARVO by Nicox
May 11, 2015: Promising preclinical data on NCX 470 for glaucoma presented at ARVO by Nicox
Apr 23, 2015: Aerie Pharmaceuticals Reports Initial Rhopressa Phase 3 Efficacy Results
Mar 24, 2015: Aerie Pharmaceuticals Completes Enrollment in Second Phase 3 Registration Trial of Rhopressa, Novel Triple-Action Product to Lower Intraocular Pressure in Patients with Glaucoma
Clinical Trial Profiles
Clinical Trial Overview of Top Companies
Novartis AG
Clinical Trial Overview of Novartis AG
Actavis plc
Clinical Trial Overview of Actavis plc
Pfizer Inc.
Clinical Trial Overview of Pfizer Inc.
Santen Pharmaceutical Co., Ltd.
Clinical Trial Overview of Santen Pharmaceutical Co., Ltd.
Aerie Pharmaceuticals, Inc.
Clinical Trial Overview of Aerie Pharmaceuticals, Inc.
Valeant Pharmaceuticals International, Inc.
Clinical Trial Overview of Valeant Pharmaceuticals International, Inc.
Merck & Co., Inc.
Clinical Trial Overview of Merck & Co., Inc.
QLT Inc.
Clinical Trial Overview of QLT Inc.
Mati Therapeutics Inc.
Clinical Trial Overview of Mati Therapeutics Inc.
Kowa Company, Ltd.
Clinical Trial Overview of Kowa Company, Ltd.
Clinical Trial Overview of Top Institutes / Government
Medical University of Vienna
Clinical Trial Overview of Medical University of Vienna
Aristotle University Of Thessaloniki
Clinical Trial Overview of Aristotle University Of Thessaloniki
University of Colorado Denver
Clinical Trial Overview of University of Colorado Denver
University of Sao Paulo
Clinical Trial Overview of University of Sao Paulo
Association for Research in Supporting System of Chronic Diseases
Clinical Trial Overview of Association for Research in Supporting System of Chronic Diseases
Department of Health, South Africa
Clinical Trial Overview of Department of Health, South Africa
IRCCS Fondazione G.B. Bietti per lo Studio e la Ricerca in Oftalmologia ONLUS
Clinical Trial Overview of IRCCS Fondazione G.B. Bietti per lo Studio e la Ricerca in Oftalmologia ONLUS
University Health Network
Clinical Trial Overview of University Health Network
University of Nebraska
Clinical Trial Overview of University of Nebraska
University of Parma
Clinical Trial Overview of University of Parma
Five Key Clinical Profiles
Appendix
Abbreviations
Definitions
Research Methodology
Secondary Research
About GlobalData
Contact Us
Disclaimer
Source

LIST OF TABLES

Ocular Hypertension Therapeutics, Global, Clinical Trials by Region, 2015
Ocular Hypertension Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015
Ocular Hypertension Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015
Ocular Hypertension Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015
Ocular Hypertension Therapeutics Clinical Trials, Europe, Top Five Countries, 2015
Ocular Hypertension Therapeutics Clinical Trials, North America, Top Countries, 2015
Ocular Hypertension Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2015
Ocular Hypertension Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2015
Proportion of Ocular Hypertension to Ophthalmology Clinical Trials, G7 Countries (%), 2015
Ocular Hypertension Therapeutics, G7 Countries, Clinical Trials by Phase, 2015
Ocular Hypertension Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015
Proportion of Ocular Hypertension to Ophthalmology Clinical Trials, E7 Countries (%), 2015
Ocular Hypertension Therapeutics, E7 Countries, Clinical Trials by Phase, 2015
Ocular Hypertension Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015
Ocular Hypertension Therapeutics, Global, Clinical Trials by Phase, 2015
Ocular Hypertension Therapeutics, Global, Clinical Trials In Progress by Phase 2015
Ocular Hypertension Therapeutics, Global, Clinical Trials by Trial Status, 2015
Ocular Hypertension Therapeutics Clinical Trials, Global, by End Point Status, 2015
Ocular Hypertension Therapeutics, Global, Suspended Clinical Trials, 2015
Ocular Hypertension Therapeutics, Global, Withdrawn Clinical Trials, 2015
Ocular Hypertension Therapeutics, Global, Terminated Clinical Trials, 2015
Ocular Hypertension Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
Ocular Hypertension Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015
Ocular Hypertension Therapeutics Clinical Trials, Global, Key Sponsors, 2015
Ocular Hypertension Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015
Ocular Hypertension Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015
Ocular Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2015
Ocular Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Actavis plc, 2015
Ocular Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2015
Ocular Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Santen Pharmaceutical Co., Ltd., 2015
Ocular Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Aerie Pharmaceuticals, Inc., 2015
Ocular Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Valeant Pharmaceuticals International, Inc., 2015
Ocular Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2015
Ocular Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by QLT Inc., 2015
Ocular Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Mati Therapeutics Inc., 2015
Ocular Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Kowa Company, Ltd., 2015
Ocular Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical University of Vienna, 2015
Ocular Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Aristotle University Of Thessaloniki, 2015
Ocular Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Colorado Denver, 2015
Ocular Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Sao Paulo, 2015
Ocular Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Association for Research in Supporting System of Chronic Diseases, 2015
Ocular Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Department of Health, South Africa, 2015
Ocular Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by IRCCS Fondazione G.B. Bietti per lo Studio e la Ricerca in Oftalmologia ONLUS, 2015
Ocular Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by University Health Network, 2015
Ocular Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Nebraska, 2015
Ocular Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Parma, 2015

LIST OF FIGURES

Ocular Hypertension Therapeutics, Global, Clinical Trials by Region (%), 2015
Ocular Hypertension Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015
Ocular Hypertension Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015
Ocular Hypertension Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015
Ocular Hypertension Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015
Ocular Hypertension Therapeutics Clinical Trials, North America, Top Countries (%), 2015
Ocular Hypertension Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2015
Ocular Hypertension Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2015
Proportion of Ocular Hypertension to Ophthalmology Clinical Trials, G7 Countries (%), 2015
Ocular Hypertension Therapeutics, G7 Countries, Clinical Trials by Phase, 2015
Ocular Hypertension Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015
Proportion of Ocular Hypertension to Ophthalmology Clinical Trials, E7 Countries (%), 2015
Ocular Hypertension Therapeutics, E7 Countries, Clinical Trials by Phase, 2015
Ocular Hypertension Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015
Ocular Hypertension Therapeutics, Global, Clinical Trials by Phase (%), 2015
Ocular Hypertension Therapeutics, Global, Clinical Trials In Progress by Phase, 2015
Ocular Hypertension Therapeutics, Global, Clinical Trials by Trial Status, 2015
Ocular Hypertension Therapeutics Clinical Trials, Global, by End Point Status, 2015
Ocular Hypertension Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
Ocular Hypertension Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015
Ocular Hypertension Therapeutics Clinical Trials, Global, Key Sponsors, 2015
Ocular Hypertension Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015
Ocular Hypertension Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015
GlobalData Methodology

COMPANIES MENTIONED

Novartis AG
Actavis plc
Pfizer Inc.
Santen Pharmaceutical Co., Ltd.
Aerie Pharmaceuticals, Inc.
Valeant Pharmaceuticals International, Inc.
Merck & Co., Inc.
QLT Inc.
Mati Therapeutics Inc.
Kowa Company, Ltd.
Skip to top


Ask Your Question

Ocular Hypertension Global Clinical Trials Review, H1, 2015
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: